131 related articles for article (PubMed ID: 1740175)
21. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of human malaria parasites to chloroquine is pH dependent.
Yayon A; Cabantchik ZI; Ginsburg H
Proc Natl Acad Sci U S A; 1985 May; 82(9):2784-8. PubMed ID: 3887411
[TBL] [Abstract][Full Text] [Related]
23. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
24. Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin.
Vega-Rodríguez J; Pastrana-Mena R; Crespo-Lladó KN; Ortiz JG; Ferrer-Rodríguez I; Serrano AE
PLoS One; 2015; 10(5):e0128212. PubMed ID: 26010448
[TBL] [Abstract][Full Text] [Related]
25. Malaria studies in vitro. IV: Chloroquine resistance and the intracellular pH of erythrocytes parasitised with Plasmodium berghei.
Williams SG; Fanimo O
Ann Trop Med Parasitol; 1975 Sep; 69(3):301-9. PubMed ID: 239645
[TBL] [Abstract][Full Text] [Related]
26. Role of the neurotransmitter reuptake-blocking activity of antidepressants in reversing chloroquine resistance in vitro in Plasmodium falciparum.
Taylor D; Walden JC; Robins AH; Smith PJ
Antimicrob Agents Chemother; 2000 Oct; 44(10):2689-92. PubMed ID: 10991845
[TBL] [Abstract][Full Text] [Related]
27. Persistence of drug-resistant malaria parasites.
Rosario VE; Hall R; Walliker D; Beale GH
Lancet; 1978 Jan; 1(8057):185-7. PubMed ID: 74609
[TBL] [Abstract][Full Text] [Related]
28. The effect of chloroquine on the production of interferon-gamma, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice.
Rosa R; Silveira H; Seixas E; Rolão N; Santos-Gomes G; do Rosário V
J Parasitol; 1999 Oct; 85(5):956-60. PubMed ID: 10577734
[TBL] [Abstract][Full Text] [Related]
29. Reversal of chloroquine resistance with verapamil in P. berghei in vivo.
Valecha N; Biswas S; Dewan S; Bhambhani S
Indian J Malariol; 1992 Mar; 29(1):47-53. PubMed ID: 1459299
[TBL] [Abstract][Full Text] [Related]
30. Fitness of drug-resistant malaria parasites.
Walliker D; Hunt P; Babiker H
Acta Trop; 2005 Jun; 94(3):251-9. PubMed ID: 15845348
[TBL] [Abstract][Full Text] [Related]
31. Reversal of chloroquine resistance in Plasmodium falciparum by CDR 87/209 and analogues.
Walter RD; Seth M; Bhaduri AP
Trop Med Parasitol; 1993 Mar; 44(1):5-8. PubMed ID: 8516635
[TBL] [Abstract][Full Text] [Related]
32. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.
Mang'era CM; Mbai FN; Omedo IA; Mireji PO; Omar SA
Acta Trop; 2012 Sep; 123(3):202-7. PubMed ID: 22641431
[TBL] [Abstract][Full Text] [Related]
33. A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites.
Lehane AM; Hayward R; Saliba KJ; Kirk K
J Cell Sci; 2008 May; 121(Pt 10):1624-32. PubMed ID: 18445688
[TBL] [Abstract][Full Text] [Related]
34. Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.
Lu F; Zhang M; Culleton RL; Xu S; Tang J; Zhou H; Zhu G; Gu Y; Zhang C; Liu Y; Wang W; Cao Y; Li J; He X; Cao J; Gao Q
Parasit Vectors; 2017 Jul; 10(1):355. PubMed ID: 28747223
[TBL] [Abstract][Full Text] [Related]
35. Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains.
Ferrari V; Cutler DJ
Biochem Pharmacol; 1991 Dec; 42 Suppl():S167-79. PubMed ID: 1768274
[TBL] [Abstract][Full Text] [Related]
36. Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers.
van Schalkwyk DA; Walden JC; Smith PJ
Antimicrob Agents Chemother; 2001 Nov; 45(11):3171-4. PubMed ID: 11600373
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
38. Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi.
Miyata Y; Fujii H; Uenohara Y; Kobayashi S; Takeuchi T; Nagase H
Bioorg Med Chem Lett; 2012 Aug; 22(16):5174-6. PubMed ID: 22818080
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
Chimanuka B; François G; Timperman G; Heyden YV; Holenz J; Plaizier-Vercammen J; Bringmann G
Parasitol Res; 2001 Oct; 87(10):795-803. PubMed ID: 11688884
[TBL] [Abstract][Full Text] [Related]
40. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]